News
DiscGenics, Inc., a privately held, late-stage clinical, biopharmaceutical company developing allogeneic, cell-based, regenerative therapies for musculoskeletal degeneration, today announced that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback